Calidi Biotherapeutics (CLDI) Long-Term Debt Issuances (2022 - 2024)
Calidi Biotherapeutics' quarterly Long-Term Debt Issuances came in at -$2.8 million in Q4 2024, down 200.0% quarter-over-quarter from $2.8 million in Q3 2024.
Calidi Biotherapeutics has reported Long-Term Debt Issuances for 3 years, with the latest figure at -$2.8 million in Q4 2024.
- For the quarter ending Q4 2024, Long-Term Debt Issuances changed N/A year-over-year to -$2.8 million; the trailing twelve-month figure through Dec 2024 stood at $200000.0 (down 84.0% YoY), and the FY2024 full-year result was $200000.0, down 84.0% from the prior year.
- Long-Term Debt Issuances for Q4 2024 stood at -$2.8 million, down from $2.8 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $3.0 million in Q1 2024, with the low at -$2.8 million in Q2 2024.
- Average Long-Term Debt Issuances over 3 years is $243750.0, with a median of $625000.0 recorded in 2023.
- Peak annual rise in Long-Term Debt Issuances reached 300.0% in 2024, while the deepest fall reached 660.0% in 2024.
- Tracing CLDI's Long-Term Debt Issuances over 3 years: stood at -$1.9 million in 2022, then surged by 126.32% to $500000.0 in 2023, then tumbled by 660.0% to -$2.8 million in 2024.
- The last three Long-Term Debt Issuances figures came in at -$2.8 million (Q4 2024), $2.8 million (Q3 2024), and -$2.8 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 2.73 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Calidi Biotherapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.80 Mn |
| Dec 31, 2024 | -2.80 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | -2.80 Mn |
| Jun 30, 2024 | -2.80 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Jun 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Dec 31, 2022 | -1.90 Mn |
| Dec 31, 2022 | -1.90 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Sep 30, 2022 | 2.40 Mn |